Legault, Isabelle
Faubert, Jocelyn
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé (293528)
Article History
Received: 30 January 2023
Accepted: 11 April 2024
First Online: 15 April 2024
Competing interests
: One of the authors is director of Faubertlab at the University of Montreal and he is the Chief Science Officer of Cognisens Athletics Inc. who produces the commercial version of the NeuroTracker used in this study. In this capacity, he holds shares in the company. This does not alter our adherence to your journal policies on sharing data and materials. The other author has no competing interest.